Friday 6 November 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
334.21
5.47
−1.61%
Follow COR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 7 | 7 |
| 132.25% | 106.98% | 96.34% | 0.00% | ||
| 2.20% | 3.33% | 3.33% | 4.26% | ||
ROIC |
20.29% | 12.64% | 15.65% | 24.40% | |
Return on Tangible Assets |
(64.24%) | (1,370.54%) | (256.39%) | (391.32%) | |
Average Days of Receivables |
29.11 | 27.64 | 27.91 | 28.49 | |
Free Cash Flow per Share |
18.79 | 8.23 | 21.26 | 20.34 | |
Free Cash Flow |
3,650.33 | 1,601.89 | 4,105.92 | 3,880.67 | |
Capital Expenditures |
(638.41) | (674.25) | (715.03) | (909.50) | |
| Other line items | |||||
Cash ROIC |
31.01% | 8.83% | 23.10% | 19.57% | |
Accounts Receivable Turnover |
12.90 | 13.52 | 13.31 | 13.09 | |
Accounts Payable Turnover |
5.92 | 6.20 | 6.04 | 5.74 | |
Inventory Turnover |
14.08 | 16.22 | 15.52 | 15.46 | |
Average Days of Payables |
65.21 | 59.90 | 62.48 | 65.45 | |
Days of Inventory on Hand |
28.01 | 23.10 | 24.02 | 24.10 | |
Tax Rate |
(0.30) | (0.27) | (0.27) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.09% | 2.19% | 2.30% | 2.39% | |
Share Based Compensation of Revenue |
0.04% | 0.04% | 0.04% | 0.00% | |
Interest Coverage |
7.98 | 7.49 | 7.05 | 8.02 | |
Operating CF/Net income |
2.64 | 0.89 | 1.84 | 1.37 | |
Depreciation/Fixed assets |
0.43 | 0.37 | 0.38 | 0.00 | |
Capex/Depreciation |
(0.61) | (0.64) | (0.67) | 0.00 | |
Revenue per Share |
1,677.37 | 1,689.48 | 1,722.89 | 1,768.08 | |
Operating CF per Share |
22.08 | 11.70 | 24.96 | 25.10 | |
Capex per Share |
(3.29) | (3.47) | (3.70) | (4.77) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026